XRD-0394

CAT: 0804-HY-162472-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0804-HY-162472-01Size:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
XRD-0394 is a potent and orally active dual ATM and DNA-PKcs inhibitor with IC50s of 0.39 nM and 0.89 nM, respectively. XRD-0394 shows selectivity over other PIKK and PI3K family members. XRD-0394 significantly enhances tumor cell killing in vitro and in vivo under therapeutic ionizing radiation conditions. XRD-0394 can potentiate the effects of PARP and topoisomerase I inhibitors in vitro[1].
CAS Number
[2595308-10-2]
UNSPSC
12352005
Target
ATM/ATR; DNA-PK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; PI3K/Akt/mTOR
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/xrd-0394.html
Purity
98.54
Solubility
DMSO : 5 mg/mL (ultrasonic)
Smiles
O=C(C12CCC2)N(C)C3=C1C4=CC(C5=CN=C(OCCNC(C)C)C(NS(C)(=O)=O)=C5)=C(F)C=C4N=C3
Molecular Formula
C26H30FN5O4S
Molecular Weight
527.61
References & Citations
[1]Gilmer T M, et al. A novel dual ATM/DNA-PK inhibitor, XRD-0394, potently radiosensitizes and potentiates PARP and topoisomerase I inhibitors[J]. Molecular Cancer Therapeutics, 2024.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 1

Related Products

CatalogName
HY-118904VL-0395
HY-156374-01D359-0396
HY-18944-01FIT-039
HY-50722-01NNC 55-0396
HY-143439LX-039
HY-50722A-01(Rac) -NNC 55-0396
HY-126143CHMFL-ABL-039
HY-111874SNIPER (ABL) -039
HY-18944R-01FIT-039 (Standard)
HY-148821BJG-05-039

Alternative Products

CatalogName
T87647-01XRD-0394
MBS5784676XRD 489
182002SODIUM THIOSULFATE0.0394 N - 1GALLON
12-8176-1.0Anti-THC (Clone THC-0394)
235487CMKC-0394-7634 Pre-sized Labels for Printers

Popular Products